Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease

Lithium increases iodine retention in the thyroid gland and inhibits thyroid hormone release. Although lithium has been reported to improve the efficacy of radioactive iodine (RAI) treatment in Graves' disease, its role as an adjunct to RAI treatment of hyperthyroidism, particularly in toxic nodular disease, remains contentious.

[1]  M. Płazińska,et al.  Lithium carbonate pre-treatment in 131-I therapy of hyperthyroidism. , 2011, Nuclear medicine review. Central & Eastern Europe.

[2]  A. Pinchera,et al.  Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. , 2010, The Journal of clinical endocrinology and metabolism.

[3]  J. Lazarus.  Lithium and thyroid. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[4]  S. Gough,et al.  Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism , 2009, Clinical endocrinology.

[5]  L. Mansi,et al.  Radioiodine in the management of benign thyroid disease: clinical guidelines. Report of a Working Party, 2007. Royal College of Physicians (RCP) , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  D. Dazzi,et al.  Radioiodine treatment of non-toxic multinodular goitre: effects of combination with lithium , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  T. Luukkaala,et al.  Long‐term follow‐up study of radioiodine treatment of hyperthyroidism , 2004, Clinical endocrinology.

[8]  W. Leslie,et al.  A randomized comparison of radioiodine doses in Graves' hyperthyroidism. , 2003, The Journal of clinical endocrinology and metabolism.

[9]  A. Pinchera,et al.  Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease. , 2002, The Journal of clinical endocrinology and metabolism.

[10]  C. Bal,et al.  A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. , 2002, Thyroid : official journal of the American Thyroid Association.

[11]  P. Larsen,et al.  High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease. , 2002, The Journal of clinical endocrinology and metabolism.

[12]  J. Franklyn,et al.  Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. , 2001, The Journal of clinical endocrinology and metabolism.

[13]  A. Pinchera,et al.  Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. , 1999, The Journal of clinical endocrinology and metabolism.

[14]  G. Kahaly,et al.  Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long‐term prospective study , 1998, Clinical endocrinology.

[15]  M. Nardi,et al.  Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. , 1998, The New England journal of medicine.

[16]  C. Sawin,et al.  Radioiodine and thyroid disease: the beginning. , 1996, Seminars in nuclear medicine.

[17]  F I Gilbert,et al.  Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  S. Tarui,et al.  Inhibitory effect of lithium on the release of thyroid hormones from thyrotropin-stimulated mouse thyroids in a perifusion system. , 1989, Endocrinology.

[19]  J. Robbins.  Perturbations of iodine metabolism by lithium , 1984 .

[20]  J. Turner,et al.  LITHIUM AS AN ADJUNCT TO RADIOIODINE THERAPY FOR THYROTOXICOSIS , 1976, The Lancet.

[21]  J. Wolff,et al.  The use of lithium in the treatment of thyrotoxicosis. , 1972, The Journal of clinical investigation.